Single and multiple human papillomavirus infections in cervical abnormalities in Portuguese women

Clinical Microbiology and Infection

Volumn 17, Issue 6, 2011, Pages 941-946

  Pista, A ^a   Oliveira, A ^a   Verdasca, N ^a   Ribeiro, F ^a  

^a NATIONAL INSTITUTE OF HEALTH DR RICARDO JORGE   (Portugal)

Author keywords

Cervical neoplasia; Genotyping; Microarray; Multiple infections; Type specific HPV

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CANCER RISK; CORRELATION ANALYSIS; FEMALE; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PAPILLOMAVIRUS INFECTION; PORTUGAL; PREVALENCE; PRIORITY JOURNAL; RECURRENT INFECTION; RISK FACTOR; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX DISEASE; VIRUS DETECTION; VIRUS STRAIN; VIRUS TYPING;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES;

EID: 79959303603     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2010.03387.x     Document Type: Article

References (32)

1. World Health Organization. Comprehensive cervical cancer control: a guide to essential practice. Geneva: WHO, 2006.
2. Munoz N, Bosch FX, de Sanjose S et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003; 348: 518-527.
3. de Villiers EM, Fauquet C, Broker TR et al. Classification of papillomaviruses. Virology 2004; 324: 17-27.
4. Ferlay J, Bray F, Pisani P, Parkin D. Globocan 2002: Cancer incidence, mortality and prevalence worldwide, version 2.0. IARC Cancer Base no. 5 ed. Lyon: IARC Press, 2004.
5. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999; 189: 12-19.
6. Bosch FX, Lorincz A, Munoz N et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002; 55: 244-265.
7. Bulkmans NW, Berkhof J, Rozendaal L et al. Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasias grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial. Lancet 2007; 370: 1764-1772.
8. Cuzick J, Arbyn M, Sankaranarayanan R et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008; 26: 29-41.
9. Szarewski A, Ambroisine L, Cadman L et al. Comparison of predictors for high-grade cervical intraepithelial neoplasia in women with abnormal smears. Cancer Epidemiol Biomarkers Prev 2008; 17: 3033-3042.
10. Nielsen A, Kjaer SK, Munk C, Iftner T. Type-specific HPV infection and multiple HPV types: prevalence and risk factor profile in nearly 12, 000 younger and older Danish women. Sex Transm Dis 2008; 35: 276-282.
11. Franco EL, Villa LL, Sobrinho JP et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high risk area for cervical cancer. J Infect Dis 1999; 180: 1415-1423.
12. Liaw KL, Hildesheim A, Burk RD et al. A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV types. J Infect Dis 2001; 183: 8-15.
13. Herrero R, Hildesheim A, Bratti C et al. Population-based study of human papillomavirus infection and cervical neoplasia in Rural Costa Rica. J Natl Cancer Inst 2000; 92: 464-473.
14. Herrero R, Castle PE, Schiffman M et al. Epidemiologic profile of type-specific human papillomavirus infection and cervical neoplasia in Guanacaste, Costa Rica. J Infect Dis 2005; 191: 1796-1807.
15. Levi JE, Kleter B, Quint WGV et al. High prevalence of human papillomavirus (HPV) infections and high frequency of multiple HPV genotypes in human immunodeficiency virus-infected women in Brazil. J Clin Microbiol 2002; 40: 3341-3345.
16. Cuschieri KS, Cubie HA, Whitley MW et al. Multiple high risk HPV infections are common in cervical neoplasia and young women in a cervical screening population. J Clin Pathol 2004; 57: 68-72.
17. Gargiulo F, De Francesco MA, Schreiber C et al. Prevalence and distribution of single and multiple HPV infections in cytologically abnormal cervical samples from Italian women. Virus Res 2007; 125: 176-182.
18. Trottier H, Mahmud S, Prado JC et al. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 2008; 15: 1436-1447.
19. Sandri MT, Riggio D, Salvatici M et al. Typing of human papillomavirus in women with cervical lesions: prevalence and distribution of different genotypes. J Med Virol 2009; 81: 271-277.
20. Selva L, Gonzalez-Bosquet E, Rodriguez-Plata MT et al. Detection of human papillomavirus infection in women attending a colposcopy clinic. Diagn Microbiol Infect Dis 2009; 64: 416-421.
21. Spinillo A, Dal Bello B, Gardella B et al. Multiple human papillomavirus infection and high grade cervical intraepithelial neoplasia among women with cytological diagnosis of atypical squamous cells of undetermined significance or low grade squamous intraepithelial lesions. Gynecol Oncol 2009; 113: 115-119.
22. Trotier H, Salaheddin M, Costa MC et al. Human papillomavirus infections with multiple types and risk of cervical neoplasia. Cancer Epidemiol Biomarkers Prev 2006; 15: 1274-1280.
23. Wentzensen N, Schiffman M, Dunn ST et al. Grading the severity of cervical neoplasia based on combined histopathology, cytopathology, and HPV genotype distribution among 1, 700 women referred to colposcopy in Oklahoma. Int J Cancer 2009; 124: 964-969.
24. International Agency for Research on Cancer (IARC) Monograph Working Group. Special report: policy. A review of human carcinogens-Part B: biological agents. Lancet 2009; 10: 321-322.
25. Clifford G, Franceschi S, Diaz M et al. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006; 24: 26-34.
26. Steben M, Duarte-Franco E. Human papillomavirus infection: epidemiology and pathophysiology. Gynecol Oncol 2007; 107: 2-5.
27. Nobre RJ, Cruz E, Real O et al. Characterization of common and rare human papillomaviruses in Portuguese women by the polymerase chain reaction, restriction fragment length polymorphism and sequencing. J Med Virol 2010; 82: 1024-1032.
28. Bosch FX, Burchell AN, Schiffman M et al. Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia. Vaccine 2008; 26: 1-16.
29. Prétet JL, Jacquard AC, Saunier M et al. Human papillomavirus genotype distribution in low-grade squamous intraepithelial lesions in France and comparison with CIN2/3 and invasive cervical cancer: the EDITH III study. Gynecol Oncol 2008; 110: 179-184.
30. Gonçalves MA, Randi G, Arslan A et al. HPV type infection in different anogenital sites among HIV-positive Brazilian women. Infect Agent Cancer 2008; 3: 5-11.
31. Schiffman M, Castle PE. Human papillomavirus: epidemiology and public health. Arch Pathol Lab Med 2003; 127: 930-934.
32. Ho GYF, Studentsov YY, Bieman R, Burk RD. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev 2004; 13: 110-116.